Medical Condition News

RSS

Sleep-targeted intervention can help prevent suicidal thoughts

Treating sleep problems with cognitive-behavioral therapy for insomnia can reduce suicidal ideation, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.

14 Jun 2011

Researchers find how collagen production helps drive tumour growth, development

Cancer Research UK scientists have revealed how the dense tissue that surrounds tumours helps drive tumour growth and development, according to research published in the journal Cancer Cell.

14 Jun 2011

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Ambit Biosciences Corporation and Astellas Pharma Inc. announced today results from a planned interim analysis in an ongoing Phase 2 study evaluating AC220, a potent and selective FLT3 inhibitor.

14 Jun 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.

14 Jun 2011

Tiotropium Respimat inhalers can increase risk of death in patients with bronchitis, emphysema

An inhaler designed to help chronic bronchitis and emphysema sufferers breathe could be significantly increasing their risk of dying, according to new research by the University of East Anglia (UEA) and three US universities.

14 Jun 2011

Genetic link to migraine found

In a latest study researchers have discovered a trio of genes tied to migraine headaches, including one in which the link is exclusive to women.

13 Jun 2011

Oncogene Aurora A may contribute to polycystic kidney disease

The Aurora A kinase may contribute to polycystic kidney disease (PKD) by inactivating a key calcium channel in kidney cells, according to a study in the June 13 issue of The Journal of Cell Biology.

13 Jun 2011

Frontal cerebral thermal transfer can eliminate insomnia symptoms

People with primary insomnia may be able to find relief by wearing a cap that cools the brain during sleep, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).

13 Jun 2011

Policy issues related to dual-eligible patients, cancer medication coverage attract headlines

The Associated Press reports that seniors are facing Medicare cost barriers which sometimes lead them to not fill cancer drug prescriptions. Also, CQ HealthBeat reports that a special team within the Department of Health and Human Services is working on finding ways to save money and improve care for patients on both Medicare and Medicaid.

13 Jun 2011

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.

13 Jun 2011

New tool to rapidly assess risk of aggressive, violent behavior by children and adolescents

Researchers at Cincinnati Children's Hospital Medical Center have developed a tool to rapidly assess the risk of aggressive and violent behavior by children and adolescents hospitalized on psychiatric units. Ultimately, they hope to use the questionnaire to improve treatment and prevention of aggressive behavior in schools and in the community.

13 Jun 2011

Daytime sleepiness influences brain's response to food and affects eating behavior

Daytime sleepiness may affect inhibitory control in the brain when viewing tantalizing, high-calorie foods, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).

13 Jun 2011

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Alexion Pharmaceuticals, Inc. today announced the presentation of research that provides further insight into the clinical consequences of paroxysmal nocturnal hemoglobinuria (PNH), and positive impact of Soliris® (eculizumab) therapy on long-term outcomes.

13 Jun 2011

New drug more effective than standard treatment to prevent heart-attack deaths

Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented if a new drug, ticagrelor, was used instead of the standard treatment, clopidogrel.

13 Jun 2011

Survey reveals increase in drinking, cannabis use and psychological distress

The latest survey of Ontario adults from the Centre for Addiction and Mental Health (CAMH) shows increasing rates of daily drinking and cannabis use and high levels of psychological distress. The results of the 2009 CAMH Monitor survey, the longest running survey tracking mental health and addiction indicators among adults in Ontario, were published today.

13 Jun 2011

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.

13 Jun 2011

Sarcoma UK releases inspiring film about people's experiences of living with bone cancer

Sarcoma UK releases an inspiring film about the experiences of people living with a rare form of cancer of soft tissue and bone, as part of Sarcoma Awareness Week.

13 Jun 2011

Trimeris, Synageva enter definitive merger agreement

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, and Trimeris, Inc., announced today that they have entered into a definitive agreement under which Synageva will merge with Trimeris in an all-stock transaction.

13 Jun 2011

Servier, Cortex sign new option agreement for AMPAKINE technology

Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.

13 Jun 2011

Patients with multiple sclerosis can benefit from group therapy sessions

Offering Multiple Sclerosis sufferers emotional support through group therapy sessions could improve their quality of life and save the NHS almost £500 per patient, a study at The University of Nottingham has discovered.

13 Jun 2011

Medical Condition News

Sleep-targeted intervention can help prevent suicidal thoughts

Researchers find how collagen production helps drive tumour growth, development

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Tiotropium Respimat inhalers can increase risk of death in patients with bronchitis, emphysema

Genetic link to migraine found

Oncogene Aurora A may contribute to polycystic kidney disease

Frontal cerebral thermal transfer can eliminate insomnia symptoms

Policy issues related to dual-eligible patients, cancer medication coverage attract headlines

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

New tool to rapidly assess risk of aggressive, violent behavior by children and adolescents

Daytime sleepiness influences brain's response to food and affects eating behavior

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

New drug more effective than standard treatment to prevent heart-attack deaths

Survey reveals increase in drinking, cannabis use and psychological distress

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

Sarcoma UK releases inspiring film about people's experiences of living with bone cancer

Trimeris, Synageva enter definitive merger agreement

Servier, Cortex sign new option agreement for AMPAKINE technology

Patients with multiple sclerosis can benefit from group therapy sessions

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News